封面
市場調查報告書
商品編碼
2076017

SNP基因型鑒定和分析市場:按技術、應用和地區分類

SNP Genotyping and Analysis Market, By Technology, By Applications, and By Region

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計,SNP基因型鑒定和分析市場在2026年將達到366.4億美元,預計2033年將達到1,482.5億美元。預計從2026年到2033年,該市場將以22.1%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 366.4億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 22.10% 2033年市場規模預測: 1482.5億美元

辨識和分析個體遺傳物質(例如DNA)中的單核苷酸多態性(SNP)的過程稱為SNP基因型鑒定。 SNP是人類基因組中最常見的遺傳變異,指的是DNA序列特定位置上單一核苷酸鹼基(A、T、C或G)的變異。 SNP基因型鑒定在遺傳研究中至關重要,因為SNP可能與多種性狀、疾病和藥物反應有關。透過識別和研究這些遺傳變異,科學家可以深入了解導致特定性狀和疾病的潛在遺傳過程。常用的SNP基因型鑒定方法包括DNA微陣列(將含有SNP的DNA片段與已知SNP序列的晶片進行雜交)和基於定序的方法,例如Sanger定序和次世代定序(NGS)技術。 SNP基因型鑒定的結果可以提供個別基因組中特定SNP等位基因存在的資訊。這些數據可用於研究特定 SNP 與性狀、疾病或藥物反應之間的關聯,以及用於群體遺傳學研究、遺傳祖先分析和精準醫療應用。

市場動態

國際組織推出的尖端SNP基因型鑒定服務預計將在分析期內促進市場發展。例如,2021年4月,由眾多貢獻者組成的策略聯盟-國際農業研究諮詢組織(CGIAR)育種卓越計畫(Breeding Excellence Programme)宣布推出一項新的低成本、高通量基因型鑒定服務。該計劃在全球15個中心開展工作。這項服務將使開發中國家的育種計畫在培育關鍵作物品種方面取得顯著進展。低密度SNP基因型鑒定服務(LDSG)為育種者提供精簡、集中的服務,以及訓練和指導。此服務應用廣泛,可望加速改良品種的開發,並提升作物育種計畫的效果。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數介紹了全球 SNP基因型鑒定和分析市場主要參與者的概況:公司概況、產品系列、主要亮點、財務績效和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 全球 SNP基因型鑒定和分析市場報告的目標受群眾外包括該行業的各類相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球 SNP基因型鑒定和分析市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 近期趨勢
  • 收購與合作趨勢
  • 技術概述
  • 監管趨勢
  • 品牌分析
  • PEST分析
  • 波特五力分析

第4章:全球SNP基因型鑒定與分析市場

  • 整體影響
  • 對供需的影響

第5章 全球SNP基因型鑒定與分析市場:依技術分類,2021-2033年

  • 概述
  • 聚合酵素鏈鎖反應
  • 微陣列
  • 次世代定序(NGS)
  • Taqman等位基因鑑定方法
  • 焦磷酸測序
  • 其他

第6章 全球SNP基因型鑒定與分析市場:依應用領域分類,2021-2033年

  • 概述
  • 診斷與法醫學
  • 藥物基因體學
  • 農業生物技術
  • 育種及畜牧業

第7章 全球SNP基因型鑒定與分析市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • Agilent Technologies Inc.
  • F. Hoffmann-La Roche Ltd
  • Nucleome Informatics Private Limited
  • Azenta Life Sciences
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Douglas Scientific LLC
  • AllGenetics & Biology SL
  • Illumina Inc.
  • Life Technologies Corp.
  • Avance Biosciences
  • Genotypic Technology Pvt Ltd
  • Xelect Ltd
  • Taconic Biosciences, Inc.
  • Luminex Corp.
  • Novacyt
  • Thermo Fischer Scientific Inc.
  • Other Prominent Players

第9章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI3972

SNP Genotyping and Analysis Market is estimated to be valued at USD 36.64 Bn in 2026 and is expected to reach USD 148.25 Bn by 2033, growing at a compound annual growth rate (CAGR) of 22.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 36.64 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 22.10% 2033 Value Projection: USD 148.25 Bn

The process of finding and analyzing single nucleotide polymorphisms (SNPs) in an individual's genetic material, such as DNA, is known as SNP genotyping. SNPs are the most prevalent technology of genetic variation identified in the human genome, and they consist of a single nucleotide base (A, T, C, or G) mutation at a specific place in the DNA sequence. SNP genotyping is important in genetic research as SNPs can be linked to a variety of traits, diseases, and drug responses. Scientists can acquire insights into the underlying genetic processes driving specific traits or diseases by identifying and studying these genetic variations. SNP genotyping methods commonly used include DNA microarrays, in which SNP-containing DNA fragments are hybridized to a chip with known SNP sequences, and sequencing-based methods such as Sanger sequencing or next-generation sequencing (NGS) technologies. The results of SNP genotyping provide information about the presence or absence of specific SNP alleles in an individual's genome. This data can be used to investigate the association of specific SNPs with traits, diseases, or drug responses, as well as to conduct population genetics studies, genetic ancestry analysis, and precision medicine applications.

Market Dynamics

Launch of state-of-the-art SNP genotyping services by international organization is anticipated to support the development of the market over the analysis period. For instance, in April 2021, The Consultative Group on International Agricultural Research (CGIAR) Excellence in Breeding program, a strategic alliance of diverse contributors that supports 15 worldwide Centers, announced new low-cost, high-throughput genotyping services, positioning breeding projects in developing countries to make significant strides in delivering critical crop varieties. The Low Density SNP Genotyping Services (LDSG) offer streamlined and centralized services to breeders, as well as training and mentoring. The services provide a variety of applications that have the potential to accelerate the generation of improved varieties and improve crop breeding programs.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global SNP genotyping and analysis market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Nucleome Informatics Private Limited, Azenta Life Sciences, Bio-Rad Laboratories Inc., Danaher Corporation, Douglas Scientific LLC, AllGenetics & Biology SL, Illumina Inc., Life Technologies Corp., Consultative Group on International Agricultural Research, Avance Biosciences, Genotypic Technology Pvt Ltd, Xelect Ltd, Taconic Biosciences, Inc., Luminex Corp., Promega Corporation, CD Genomics, Synbio Technologies, Thermo Fischer Scientific Inc., Sequenom, PREMIER Biosoft, Fluidigm Corporation, Novacyt, Twist Bioscience, Regeneron Pharmaceuticals, Inc, NRGene, and LGC Biosearch Technologies
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, Technology up-gradation, market expansion, and marketing tactics
  • Global SNP genotyping and analysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global SNP genotyping and analysis market

Detailed Segmentation:

  • Global SNP Genotyping and Analysis Market, By Technology (Revenue, USD Bn, 2021 - 2033)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Next-Generation Sequencing (NGS)
  • Taqman Allelic Discrimination
  • Pyrosequencing
  • Others
  • Global SNP Genotyping and Analysis Market, By Applications (Revenue, USD Bn, 2021 - 2033)
  • Diagnostics & Forensics
  • Pharmacogenomics
  • Agricultural Biotechnology
  • Breeding & Animal Livestock
  • Global SNP Genotyping and Analysis Market, By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
  • Agilent Technologies Inc.
  • Hoffmann-La Roche Ltd
  • Nucleome Informatics Private Limited
  • Azenta Life Sciences
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Douglas Scientific LLC
  • AllGenetics & Biology SL
  • Illumina Inc.
  • Life Technologies Corp.
  • Consultative Group on International Agricultural Research
  • Avance Biosciences
  • Genotypic Technology Pvt Ltd
  • Xelect Ltd
  • Taconic Biosciences Inc.
  • Luminex Corp.
  • Promega Corporation
  • CD Genomics
  • Synbio Technologies
  • Thermo Fischer Scientific Inc.
  • Sequenom
  • PREMIER Biosoft
  • Fluidigm Corporation
  • Novacyt
  • Twist Bioscience
  • Regeneron Pharmaceuticals, Inc
  • NRGene
  • LGC Biosearch Technologies

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Applications
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • Brand Analysis
  • PEST Analysis
  • Porter€(TM)s Analysis

4. Global SNP Genotyping and Analysis Market

  • Overall Impact
  • Impact on Supply and Demand

5. Global SNP Genotyping and Analysis Market, By Technology, 2021 - 2033, (US$ Billion)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022€"2033
    • Segment Trends
  • Polymerase Chain Reaction
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
  • Microarray
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
  • Next-Generation Sequencing (NGS)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
  • Taqman Allelic Discrimination
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
  • Pyrosequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)

6. Global SNP Genotyping and Analysis Market, By Applications, 2021€"2033, (US$ Billion)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022€"2033
    • Segment Trends
  • Diagnostics & Forensics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
  • Pharmacogenomics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
  • Agricultural Biotechnology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
  • Breeding and Animal Livestock
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)

7. Global SNP Genotyping and Analysis Market, By Region, 2021€"2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022€"2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€"2033, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€"2033, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€"2033, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€"2033, (US$ Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€"2033, (US$ Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021€"2033, (US$ Billion)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Agilent Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nucleome Informatics Private Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Azenta Life Sciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Douglas Scientific LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AllGenetics & Biology SL
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Life Technologies Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Avance Biosciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Genotypic Technology Pvt Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Xelect Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Taconic Biosciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Luminex Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novacyt
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fischer Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Other Prominent Players
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us